reclaimed the 7,000 level Thursday, driven higher by new economic data and another dose of healthcare M&A. The market was spurred this time by Swiss pharma company
agreeing to buy the remaining shares of
for $95 apiece, or $46.8 billion.
also announced it is acquiring
in a $1.4 billion cash deal that will boost Gilead's cardiovascular drug franchise. All this wheeling and dealing in the health care sector sent all three stocks onto
top ten most searched stocks list.
var config = new Array(); config<BRACKET>"videoId"</BRACKET> = 16265974001; config<BRACKET>"playerTag"</BRACKET> = "TSCM Embedded Video Player"; config<BRACKET>"autoStart"</BRACKET> = false; config<BRACKET>"preloadBackColor"</BRACKET> = "#FFFFFF"; config<BRACKET>"useOverlayMenu"</BRACKET> = "false"; config<BRACKET>"width"</BRACKET> = 265; config<BRACKET>"height"</BRACKET> = 255; config<BRACKET>"playerId"</BRACKET> = 1243645856; createExperience(config, 8);
was also heavily searched. General Electric was a strong performer on the Dow, despite Standard & Poor's having cut its rating. However, the cut was not as severe as expected.
America's biggest banks also showed up on stock search.
Bank of America's
secured its position as the biggest bank in the country, according to a report issued late Wednesday. BofA now tops the list of U.S. banks and thrifts with $2.49 trillion worth of assets, $310.4 billion more than No. 2 competitor
JPMorgan still leads Bank of America in terms of deposits, however, holding over $1 trillion in consumer dollars. Without the Merrill acquisition, BofA would have ranked third in terms of deposits behind JPMorgan and
. Behind those three banking behemoths came
made the list after saying it will book $300 million in pre-expense earnings this year. The $300 million earnings before interest depreciation and amortization, or EBITDA, target was the only forecast the satellite radio shop would provide in its conference call Thursday. Given the economic uncertainties, Sirius said it would not make any subscriber or sales projections.
was heavily searched. The company said early Thursday that a late-stage clinical trial has shown its oncology drug Sutent to be effective in slowing the progression of advanced pancreatic cancer.
was a popular topic after the company's chief financial officer said the company will not need the $2 billion loan installment for March that it requested from the U.S. government in February. GM borrowed $13.4 billion from the government earlier this year. Last month, it said it would need up to an additional $16.6 billion to keep operating, including $2 billion in March and $2.6 billion in April.
Before joining TheStreet.com, Gregg Greenberg was a writer and segment producer for CNBC's Closing Bell. He previously worked at FleetBoston and Lehman Brothers in their Private Client Services divisions, covering high net-worth individuals and midsize hedge funds. Greenberg attended New York University's School of Business and Economic Reporting. He also has an M.B.A. from Cornell University's Johnson School of Business, and a B.A. in history from Amherst College.